Pure-DEL
Z├╝rich
About Pure-DEL
Pure-DEL provides access to libraries of billions of intricate synthetic macrocycles that are specifically designed to target difficult disease targets.
Company Facts
- Operating status: Active
- IPO status: Private
- Employees: 1 – 10
- Total funding: $187.5K
- Last round: Grant (Nov 2025)
- Website: pure-del.com
Industries & Categories
Biotechnology, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/pure-del-150538 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.